top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Advances and Novel Treatment Options in Metastatic Melanoma
Advances and Novel Treatment Options in Metastatic Melanoma
Autore Facchiano Antonio
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 online resource (528 p.)
Soggetto topico Medicine and Nursing
Soggetto non controllato ABT-737
acetazolamide
acetylcholine
adjuvant therapy
amoeboid motility
angiogenesis
apoptosis
arthralgia
Bcl-2 family
BCL2L10
biomarkers
BRAF
BRAF inhibitor
BRAF inhibitors
BRAF-mutant melanoma
cancer
cancer associated fibroblast
cancer stem cells
carbonic anhydrase
cell therapy
checkpoint inhibitor
cholinergic system
combined therapy
ctDNA
CXCL10
cyclopamine
cytokines
cytotoxicity
diagnosis
DOCK4
drug resistance
essential oils
exosomes
extracellular vesicles
FAK
hedgehog
HIPPO
HuR
immunity
immunotherapy
interferon
invasion
ipilimumab
lactate dehydrogenase
lipid metabolism
liquid biopsy
liver-directed-therapies
machine learning
MANS peptide
MARCKS
mechanism of action
melanoma
melanoma immune infiltrate
melanoma markers
melanoma metastasis
melanoma PDX
melanomagenesis
metalloproteinases
metastases
metastasis
metastatic dormancy
metastatic therapy
metastatic uveal melanoma (mUM)
microenvironment
microRNAs
MITF
ML258
motility
mucosal melanoma
muscarinic receptors
n/a
nanoparticles
nicotinic receptors
nivolumab
OXPHOS
patient stratification
PD-1
pembrolizumab
phosphorylation
plasmacytoid dendritic cells
prediction
principal component analysis
prognosis
prognostication
protein tyrosine phosphatase
PTPs inhibitors
Rac1
radiotherapy
resistance
rheumatoid arthritis
sex-hormones
sex/gender
ShcD adaptor protein
siRNA
slow cycling phenotype
small molecules
SOCE
STAT3
Support Vector Machine
survival
target therapy
targeted therapy
targeted-therapy
therapeutic resistance
therapy
TLR
TPC2
tumor microenvironment
tumour microenvironment
uveal melanoma (UM)
WNT5A
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557612103321
Facchiano Antonio  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Antitumor and Anti-HIV Agents from Natural Products
Antitumor and Anti-HIV Agents from Natural Products
Autore Nakagawa-Goto Kyoko
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 online resource (338 p.)
Soggetto topico Research & information: general
Soggetto non controllato acute toxicity
allyl isothiocyanate
Angelica dahurica
anti-HIV
antiangiogenic
antioxidants
antiproliferation
antiproliferative activity
antiretroviral agents
antitumor activity
apoptosis
Artemisia absinthium L.
aspidosperma-type
benzyl isothiocyanate
bladder cancer
Bousigonia mekongensis
BRAF inhibitor
breast cancer
butanolides
caffeic acid
cancer
cancer multidrug resistance
cancer stem cell
Carpesium divaricatum
cell cycle
cell cycle arrest
cervical cancer
chemistry
chemoprevention
cisplatin
coumarins
curcumin analog
cytotoxicity
delcosine
delpheline
diterpenoid alkaloids
DOTA
drug development
drug-drug interaction
epithelial-to-mesenchymal transition
essential oil
flavonoids
G2/M phase cell cycle arrest
HaCaT cells
HEF cell line
hepatocellular carcinoma
hepatoma cells
Hernandia nymphaeifolia
human tumor cell lines
human tumor cells
inflammation
Ivalin
kobusine
lignan glycosides
lipojesaconitine
marine metabolites
matrix metalloproteinase
medicine
melanoma
melanoma and breast cancer cell line
Mentha aquatica var. Kenting Water Mint
metastasis
mitochondria-mediated apoptosis
monoterpenoid indole alkaloids
natural agents
natural phaeosphaeride A
natural products
NF-κB
oral squamous cell carcinoma cells
oxidative stress
oxypeucedanin
P-glycoprotein
p53
phenethyl isothiocyanate
phenolic acid
pseudokobusine
pterostilbene
quercetin
reactive oxygen species
resveratrol
SK-Hep-1
sulforaphane
tamoxifen
taxol
total phenolic content
transforming growth factor-β1
triterpenoids
tubulin inhibitor
tumor suppression
two-stage skin carcinogenesis
ursolic acid
β-lapachone
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557504803321
Nakagawa-Goto Kyoko  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui